Agios Pharmaceuticals Files for $86 Million IPO

Published: Jun 11, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Biopharmaceutical company Agios Pharmaceuticals Inc filed with U.S. regulators on Monday to raise up to $86 million in an initial public offering of common stock. The Cambridge, Massachusetts-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus that JP Morgan and Goldman Sachs & Co are lead underwriters in the IPO. () Agios said it was working with Celgene Corp on a program focused on cancer metabolism. Celgene, which has a 17 percent stake in Agios, has agreed to purchase an undisclosed amount of Agios stock in a separate private placement at the IPO price.

Help employers find you! Check out all the jobs and post your resume.

Back to news